The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.
The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
It was found to have 64 per cent efficacy against symptomatic disease and 92 per cent against severe COVID-19, the agency said.
Other vaccines that have similar clearance from the agency include those made by Pfizer and BioNTech, Moderna, AstraZeneca, Johnson & Johnson and Novavax.
UN establishes task force to address Hormuz navigation challenges
Bahrain contain fire at 'facility' after Iran attack
Rubio says Iran war to last 'weeks not months'; no ground troops needed
NASA's Artemis astronauts enter final preparations for Moon mission
Iran-linked hackers breach FBI director's personal email
Trump extends deadline for striking Iran's energy plants to April 7
Israeli evacuation orders uproot 370,000 children in Lebanon, UN says
UN rights chief urges US to conclude probe into deadly Iran school strike
